Björn Bornkamp

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Decision Making

Allergic Rhinitis

Top Venues

Pharmaceutical statistics

Biometrical journal. Biometrische Zeitschrift

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Björn Bornkamp, Silvia Zaoli, Michela Azzarito, Ruvie Martin, Carsten Philipp Müller, Conor Moloney, Giulia Capestro, David Ohlssen, Mark Baillie
Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation. Pharmaceutical statistics (2024)
Björn Bornkamp, Silvia Zaoli, Michela Azzarito, Ruvie Martin, Carsten Philipp Müller, Conor Moloney, Giulia Capestro, David Ohlssen, Mark Baillie
Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation. Pharmaceutical statistics 23 (4) (2024)
Olympia Papachristofi, Björn Bornkamp, Melanie Wright, Tim Friede
Interim decision making in seamless trial designs: An application in an adaptive dose-finding study in a rare kidney disease. Pharmaceutical statistics (2023)
Tianmeng Lyu, Björn Bornkamp, Guenther Mueller-Velten, Heinz Schmidli
Bayesian inference for a principal stratum estimand on recurrent events truncated by death. Biometrics (2023)
Sophie Sun, Konstantinos Sechidis, Yao Chen, Jiarui Lu, Chong Ma, Ardalan Mirshani, David Ohlssen, Marc Vandemeulebroecke, Björn Bornkamp
Comparing algorithms for characterizing treatment effect heterogeneity in randomized trials. Biometrical journal. Biometrische Zeitschrift (2022)
Björn Holzhauer, Lisa V Hampson, John Paul Gosling, Björn Bornkamp, Joseph Kahn, Markus R Lange, Wen-Lin Luo, Caterina Brindicci, David Lawrence, Steffen Ballerstedt, Anthony O'Hagan
Eliciting judgements about dependent quantities of interest: The SHeffield ELicitation Framework extension and copula methods illustrated using an asthma case study. Pharmaceutical statistics 21 (5) (2022)
Craig Wang, Yufen Zhang, Fabrizia Mealli, Björn Bornkamp
Sensitivity analyses for the principal ignorability assumption using multiple imputation. Pharmaceutical statistics (2022)
Lisa V Hampson, Björn Bornkamp, Björn Holzhauer, Joseph Kahn, Markus R Lange, Wen-Lin Luo, Giovanni Della Cioppa, Kelvin Stott, Steffen Ballerstedt
Improving the assessment of the probability of success in late stage drug development. Pharmaceutical statistics 21 (2) (2021)
Marius Thomas, Björn Bornkamp, Katja Ickstadt
Identifying treatment effect heterogeneity in dose-finding trials using Bayesian hierarchical models. Pharmaceutical statistics (2021)
Björn Bornkamp, Kaspar Rufibach, Jianchang Lin, Yi Liu, Devan V Mehrotra, Satrajit Roychoudhury, Heinz Schmidli, Yue Shentu, Marcel Wolbers
Principal stratum strategy: Potential role in drug development. Pharmaceutical statistics 20 (4) (2021)
Mouna Akacha, Christian Bartels, Björn Bornkamp, Frank Bretz, Neva Coello, Thomas Dumortier, Michael Looby, Oliver Sander, Heinz Schmidli, Jean-Louis Steimer, Camille Vong
Estimands-What they are and why they are important for pharmacometricians. CPT: pharmacometrics & systems pharmacology 10 (4) (2021)